Filing Summary
Registrant identified in the filing: China Jo-Jo Drugstores, Inc., not Ridgetech Inc. The filing is a Form 6-K for November 2023, filed November 20, 2023, and reports matters submitted to shareholders at the November 16, 2023 annual meeting for the fiscal year ended March 31, 2023.
Business Context and Reporting Period
The filing covers voting results from the annual meeting of shareholders. China Jo-Jo Drugstores, Inc. is a Cayman Islands exempted company and files annual reports on Form 20-F.
Financial Metrics and Capital Structure
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating financial metrics.
Before the approved share consolidation, authorized share capital was stated as US$6.01 million, consisting of 500 million ordinary shares with a par value of US$0.012 each and 10 million preferred shares with a par value of US$0.001 each. If a 1-for-20 ratio is implemented, authorized capital would become US$36.01 million, consisting of 150 million ordinary shares with a par value of US$0.24 each and 10 million preferred shares with a par value of US$0.001 each.
Material Changes and Shareholder Actions
- All six nominated directors were elected: Lei Liu, Li Qi, Caroline Wang, Jiangliang He, Genghua Gu, and Pingfan Wu.
- YCM CPA, Inc. was ratified as the independent registered public accounting firm for the fiscal year ending March 31, 2024.
- Shareholders approved a reverse stock split of the ordinary shares at a ratio of up to 1-for-20. The timing and final ratio remain subject to the board’s discretion.
- Shareholders approved the related authorized share capital increase and amendments to the memorandum and articles of association, subject to implementation of the reverse stock split and share consolidation.
- The Third Amended and Restated 2010 Equity Incentive Plan was approved.
Guidance, Outlook, Risks, and Unusual Items
No financial guidance or operating outlook is provided. The principal unusual corporate action is the approved reverse stock split, which may change the number of outstanding and authorized ordinary shares and the ordinary share par value. The filing states that implementation is subject to action by the board in its sole discretion; it does not specify a definitive effective date or final ratio.
Investor Verification Items
- Confirm that the filing belongs to China Jo-Jo Drugstores, Inc., rather than the company identified in the request metadata as Ridgetech Inc.
- Verify whether and when the board implements the reverse stock split and the final ratio selected.
- Review subsequent filings for the effective share count, amended constitutional documents, and impact on trading and equity incentive awards.
- Review the company’s annual report for the fiscal year ended March 31, 2023 for financial performance, liquidity, debt, and risk disclosures not included in this Form 6-K.